ArticleJAMA network open2024

Immunogenicity of 2-Dose HPV Vaccine Series for Postpartum Women: An Open-Label, Nonrandomized, Noninferiority Trial.

Chailee F Moss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.